DNTH
#1202
Dianthus Therapeutics, Inc. - Common Stock
111.5 4 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.70%
Changement Mensuel
+9.22%
Evolution sur 6 mois
+107.17%
Changement Annuel
+350.85%
Clôture Précédente
110.7 6
Open
111.5 4
Low
111.5 4
High
111.5 4
Volume
70
Financials
- Market Capitalization 6.24 B
- Employee 92
- Founded 2019
- CEO N/A
- Website www.dianthustx.com
- Headquarter Delaware, United States
- FIGI BBG00FB2NPZ0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.81
ratio cours/chiffre d'affaires
781.65
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1192 |  TVTX Travere Therapeutics, Inc. - Common Stock | 67.52 USD | +0.60% | +4.23% | +20.46% | +134.69% | 6.36 B USD | ||
| 1200 |  LQDA Liquidia Corporation - Common Stock | 69.94 USD | -1.99% | -1.37% | -19.44% | +209.47% | 6.26 B USD | ||
| 1209 |  BLTE Belite Bio Inc - American Depositary Shares | 157.01 USD | +0.20% | -3.97% | +2.48% | +146.10% | 6.18 B USD | ||
| 1228 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 61.93 USD | -2.92% | +2.45% | -5.19% | +51.83% | 6.00 B USD |